首页 > 最新文献

癌症治疗(英文)最新文献

英文 中文
Obesity in Terms of BMI and BSA in Egyptian Breast Cancer Patients: Can Tumor Behavior Be Predicted? 从BMI和BSA看埃及乳腺癌患者的肥胖:能否预测肿瘤行为?
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.136030
A. Adel, Khalid N. Abdelhakam, D. Abdelghany
{"title":"Obesity in Terms of BMI and BSA in Egyptian Breast Cancer Patients: Can Tumor Behavior Be Predicted?","authors":"A. Adel, Khalid N. Abdelhakam, D. Abdelghany","doi":"10.4236/jct.2022.136030","DOIUrl":"https://doi.org/10.4236/jct.2022.136030","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70994113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Need for a National Guideline for the Management of NSCLC ALK-Positive Lung Cancer in the UK: Results of Patient-Driven Surveys 在英国需要一个国家指南来管理非小细胞肺癌alk阳性肺癌:患者驱动调查的结果
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.137042
D. Montague
{"title":"The Need for a National Guideline for the Management of NSCLC ALK-Positive Lung Cancer in the UK: Results of Patient-Driven Surveys","authors":"D. Montague","doi":"10.4236/jct.2022.137042","DOIUrl":"https://doi.org/10.4236/jct.2022.137042","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70994799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing Cachexia and Improving Quality of Life in Cancer Patients Using Novel Nutritional Supplements: A PAN India Study 使用新型营养补充剂管理恶病质和改善癌症患者的生活质量:一项PAN印度研究
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.132007
Snany Surendran, R. Devi, Raktim Chattopadhyay, Anubhab Mukherjee, S. Charde
{"title":"Managing Cachexia and Improving Quality of Life in Cancer Patients Using Novel Nutritional Supplements: A PAN India Study","authors":"Snany Surendran, R. Devi, Raktim Chattopadhyay, Anubhab Mukherjee, S. Charde","doi":"10.4236/jct.2022.132007","DOIUrl":"https://doi.org/10.4236/jct.2022.132007","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70993180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bladder Cancer in Young Patients: Management and Outcomes 年轻患者膀胱癌:管理和结果
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.133013
C. Kamadjou, D. Eyongeta, A. Kameni, A. Mbassi, F. Angwafor
Background and Objective: Bladder cancer frequently occurs between the ages of 50 years and 70 years and rarely occurs before the age of 40 years. It accounts for 1% - 4% of all cases of cancer. This study focuses on the clinical, etiological, histological, therapeutic, and evolutive profiles of patients with bladder cancer aged less than 45 years. Materials and Methods: This retrospective study was carried out over seven years (from January 2014 to December 2020) on 15 patients below 45 years of age who were being treated for bladder cancer. The diagnosis was made in all patients via cystoscopy and abdominal computerized tomography, while the nature, grade, and degree of infiltration were determined via endoscopic resection and pathology. Results: The mean age of the 15 patients in this study was 34.4 ± 5.19 years. In 86.6% of cases, the patients had macroscopic hematuria as the main presenting complaint. Twelve patients (80%) had bladder tumors that did not infiltrate the muscle. These patients were followed up clinically. In 86.6% of cases, there was a single tumor with a mean diameter of 2.53 cm. In four patients (26.6%), mitomycin was started early. The overall rates of tumor recurrence and progression were 26.6% and 20%, respectively. Conclusion: Bladder cancer also occurs in young people, with similar clinical and epidemiological profiles as exists in elderly patients. The prognosis of bladder cancer in young people depends on the treatment method chosen by the physician.
背景与目的:膀胱癌多发生在50 ~ 70岁之间,40岁以前很少发生。它占所有癌症病例的1% - 4%。本研究的重点是年龄小于45岁的膀胱癌患者的临床、病因、组织学、治疗和进化概况。材料与方法:本回顾性研究从2014年1月至2020年12月,对15例45岁以下的膀胱癌患者进行了为期7年的回顾性研究。所有患者均通过膀胱镜检查和腹部计算机断层扫描进行诊断,并通过内镜切除和病理确定浸润的性质、分级和程度。结果:本组15例患者平均年龄34.4±5.19岁。86.6%的患者以肉眼可见的血尿为主要主诉。12例患者(80%)膀胱肿瘤未浸润肌肉。对这些患者进行临床随访。86.6%的病例为单发肿瘤,平均直径2.53 cm。4例患者(26.6%)早期开始使用丝裂霉素。肿瘤复发率和进展率分别为26.6%和20%。结论:膀胱癌在年轻人中也有发生,其临床和流行病学特征与老年患者相似。年轻人膀胱癌的预后取决于医生选择的治疗方法。
{"title":"Bladder Cancer in Young Patients: Management and Outcomes","authors":"C. Kamadjou, D. Eyongeta, A. Kameni, A. Mbassi, F. Angwafor","doi":"10.4236/jct.2022.133013","DOIUrl":"https://doi.org/10.4236/jct.2022.133013","url":null,"abstract":"Background and Objective: Bladder cancer frequently occurs between the ages of 50 years and 70 years and rarely occurs before the age of 40 years. It accounts for 1% - 4% of all cases of cancer. This study focuses on the clinical, etiological, histological, therapeutic, and evolutive profiles of patients with bladder cancer aged less than 45 years. Materials and Methods: This retrospective study was carried out over seven years (from January 2014 to December 2020) on 15 patients below 45 years of age who were being treated for bladder cancer. The diagnosis was made in all patients via cystoscopy and abdominal computerized tomography, while the nature, grade, and degree of infiltration were determined via endoscopic resection and pathology. Results: The mean age of the 15 patients in this study was 34.4 ± 5.19 years. In 86.6% of cases, the patients had macroscopic hematuria as the main presenting complaint. Twelve patients (80%) had bladder tumors that did not infiltrate the muscle. These patients were followed up clinically. In 86.6% of cases, there was a single tumor with a mean diameter of 2.53 cm. In four patients (26.6%), mitomycin was started early. The overall rates of tumor recurrence and progression were 26.6% and 20%, respectively. Conclusion: Bladder cancer also occurs in young people, with similar clinical and epidemiological profiles as exists in elderly patients. The prognosis of bladder cancer in young people depends on the treatment method chosen by the physician.","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70993447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Drug-Drug Interaction between CDK4/6 Inhibitors and Proton Pump Inhibitors on Survival Outcomes in the Treatment of Metastatic Breast Cancer—Real World Data from a Portuguese Center CDK4/6抑制剂和质子泵抑制剂之间的药物相互作用对转移性乳腺癌治疗中生存结果的影响-来自葡萄牙中心的真实世界数据
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.135022
J. Reis, Inês Costa, M. Costa, A. Valente, Catarina Almeida, M. Freitas, C. Caeiro, Catarina Fernandes, N. Tavares, M. Barbosa
{"title":"Impact of Drug-Drug Interaction between CDK4/6 Inhibitors and Proton Pump Inhibitors on Survival Outcomes in the Treatment of Metastatic Breast Cancer—Real World Data from a Portuguese Center","authors":"J. Reis, Inês Costa, M. Costa, A. Valente, Catarina Almeida, M. Freitas, C. Caeiro, Catarina Fernandes, N. Tavares, M. Barbosa","doi":"10.4236/jct.2022.135022","DOIUrl":"https://doi.org/10.4236/jct.2022.135022","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70994365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Experience of Pain and Anxiety in Cervical Cancer Patients Undergoing Multiple Fraction High-Dose Rate Brachytherapy: A Prospective Observational Study 宫颈癌患者接受多次高剂量率近距离放射治疗的疼痛和焦虑体验:一项前瞻性观察研究
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.137035
K. Benali, M. Tazi, Gaël Kietga, T. Kebdani, K. Hassouni, S. Majjaoui, H. Kacemi, N. Benjaafar
{"title":"The Experience of Pain and Anxiety in Cervical Cancer Patients Undergoing Multiple Fraction High-Dose Rate Brachytherapy: A Prospective Observational Study","authors":"K. Benali, M. Tazi, Gaël Kietga, T. Kebdani, K. Hassouni, S. Majjaoui, H. Kacemi, N. Benjaafar","doi":"10.4236/jct.2022.137035","DOIUrl":"https://doi.org/10.4236/jct.2022.137035","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70994400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of Nursing Intervention in Operating Room for Patients with Gastric Cancer during Anesthesia Recovery Period 胃癌患者麻醉恢复期手术室护理干预效果分析
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.139052
Lan Xie
{"title":"Effect of Nursing Intervention in Operating Room for Patients with Gastric Cancer during Anesthesia Recovery Period","authors":"Lan Xie","doi":"10.4236/jct.2022.139052","DOIUrl":"https://doi.org/10.4236/jct.2022.139052","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70995418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Chemotherapy on Peripheral Blood NK Cell Receptor NKG2D and Related Immune Cytokines in Patients with Non-Small Cell Lung Cancer 化疗对非小细胞肺癌患者外周血NK细胞受体NKG2D及相关免疫因子的影响
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.1311056
Jingjing Zhang, Dianbin Song, Yi Dong, Lu Bai, Dongqi Gao, Shenglin Zhang, Yan Guo, Fubo Li, Man Ao, Qingshan Li
{"title":"Effects of Chemotherapy on Peripheral Blood NK Cell Receptor NKG2D and Related Immune Cytokines in Patients with Non-Small Cell Lung Cancer","authors":"Jingjing Zhang, Dianbin Song, Yi Dong, Lu Bai, Dongqi Gao, Shenglin Zhang, Yan Guo, Fubo Li, Man Ao, Qingshan Li","doi":"10.4236/jct.2022.1311056","DOIUrl":"https://doi.org/10.4236/jct.2022.1311056","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70993030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Testicular Lymphoma: A Case Report and Review of the Literature 原发性睾丸淋巴瘤1例报告及文献复习
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.133011
Nioka Pierre Xavier Sia, T. Chekrine, M. Bourhafour, Karima Ouadii, Z. Bouchbika, N. Benchakroun, H. Jouhadi, N. Tawfiq, A. Benider, F. Marnissi, A. Madani, M. Karkouri, S. Sahraoui
Background and Aim: Primary testicular lymphoma (PTL) is a rare form of extranodal non-Hodgkin’s lymphoma. It represents for 1% 2% of non-Hodgkin’s lymphoma, and mostly affects the elderly. We describe an interesting case of PTL managed by a combined multimodal approach with a review of the literature. Case Presentation: Patient aged 56 years, consulted for an increase in the volume of the right testicle without associated pain, all evolving in the context of a slight decline in general condition. Clinical examination revealed a large painless mass in the right scrotal bursa. A scrotal ultrasound showed a right intra-testicular mass. The patient had undergone inguinal orchiectomy. Pathological analysis showed diffuse large B-cell lymphoma of the testis. Whole-body 18-fluorodeoxyglucose positron emission tomography (18-FDGPET-CT) showed no suspicious hypermetabolism. Lumbar puncture did not reveal malignant cells in the cerebrospinal fluid (CSF). The patient then received 6 cycles of chemotherapy according to the R-CHOP protocol (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) and 2 cycles of intrathecal methotrexate. After chemotherapy, scrotal radiotherapy at a dose of 30 Gy was delivered. The evolution was marked by the death of the patient six months after the end of the scrotal radiotherapy following a diffuse lymph node relapse with a profound alteration of the general state. Conclusion: The treatment depends imperatively on the stage of the disease. The therapeutic approach is multimodal and combined based on orchiectoHow to cite this paper: Sia, N.P.X., Chekrine, T., Bourhafour, M., Ouadii, K., Bouchbika, Z., Benchakroun, N., Jouhadi, H., Tawfiq, N., Benider, A., Marnissi, F., Madani, A., Karkouri, M. and Sahraoui, S. (2022) Primary Testicular Lymphoma: A Case Report and Review of the Literature. Journal of Cancer Therapy, 13, 145-154. https://doi.org/10.4236/jct.2022.133011 Received: February 10, 2022 Accepted: March 18, 2022 Published: March 21, 2022 Copyright © 2022 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/
背景与目的:原发性睾丸淋巴瘤(PTL)是一种罕见的结外非霍奇金淋巴瘤。它占非霍奇金淋巴瘤的1% - 2%,主要影响老年人。我们描述了一个有趣的PTL案例,通过结合多模式方法管理,并回顾了文献。病例介绍:患者年龄56岁,因右睾丸体积增加而就诊,无相关疼痛,均在一般情况轻微下降的背景下发展。临床检查发现右侧阴囊囊内有一无痛性大肿块。阴囊超声显示右侧睾丸内肿块。患者行了腹股沟睾丸切除术。病理分析为睾丸弥漫性大b细胞淋巴瘤。全身18-氟脱氧葡萄糖正电子发射断层扫描(18-FDGPET-CT)未显示可疑的高代谢。腰椎穿刺未发现脑脊液(CSF)中有恶性细胞。然后患者接受R-CHOP方案6个周期化疗(利妥昔单抗、环磷酰胺、阿霉素、长春新碱、强的松)和2个周期鞘内甲氨蝶呤。化疗后给予阴囊放疗,剂量为30 Gy。这一进展的标志是患者在阴囊放疗结束6个月后死亡,原因是弥漫性淋巴结复发,总体状态发生了深刻的改变。结论:治疗应根据疾病分期而定。治疗方法是基于睾丸的多模式和联合治疗。如何引用这篇论文:Sia, N.P.X, Chekrine, T., Bourhafour, M., Ouadii, K., Bouchbika, Z., Benchakroun ., Jouhadi, H., Tawfiq, N., Benider, A., Marnissi, F., Madani, A., Karkouri, M.和Sahraoui, S.(2022)原发性睾丸淋巴瘤:一个病例报告和文献回顾。中华肿瘤杂志,2013,45- 45。https://doi.org/10.4236/jct.2022.133011收稿日期:2022年2月10日收稿日期:2022年3月18日出版日期:2022年3月21日版权所有©作者/作者:Scientific Research Publishing Inc。本作品采用知识共享署名国际许可协议(CC BY 4.0)。http://creativecommons.org/licenses/by/4.0/
{"title":"Primary Testicular Lymphoma: A Case Report and Review of the Literature","authors":"Nioka Pierre Xavier Sia, T. Chekrine, M. Bourhafour, Karima Ouadii, Z. Bouchbika, N. Benchakroun, H. Jouhadi, N. Tawfiq, A. Benider, F. Marnissi, A. Madani, M. Karkouri, S. Sahraoui","doi":"10.4236/jct.2022.133011","DOIUrl":"https://doi.org/10.4236/jct.2022.133011","url":null,"abstract":"Background and Aim: Primary testicular lymphoma (PTL) is a rare form of extranodal non-Hodgkin’s lymphoma. It represents for 1% 2% of non-Hodgkin’s lymphoma, and mostly affects the elderly. We describe an interesting case of PTL managed by a combined multimodal approach with a review of the literature. Case Presentation: Patient aged 56 years, consulted for an increase in the volume of the right testicle without associated pain, all evolving in the context of a slight decline in general condition. Clinical examination revealed a large painless mass in the right scrotal bursa. A scrotal ultrasound showed a right intra-testicular mass. The patient had undergone inguinal orchiectomy. Pathological analysis showed diffuse large B-cell lymphoma of the testis. Whole-body 18-fluorodeoxyglucose positron emission tomography (18-FDGPET-CT) showed no suspicious hypermetabolism. Lumbar puncture did not reveal malignant cells in the cerebrospinal fluid (CSF). The patient then received 6 cycles of chemotherapy according to the R-CHOP protocol (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) and 2 cycles of intrathecal methotrexate. After chemotherapy, scrotal radiotherapy at a dose of 30 Gy was delivered. The evolution was marked by the death of the patient six months after the end of the scrotal radiotherapy following a diffuse lymph node relapse with a profound alteration of the general state. Conclusion: The treatment depends imperatively on the stage of the disease. The therapeutic approach is multimodal and combined based on orchiectoHow to cite this paper: Sia, N.P.X., Chekrine, T., Bourhafour, M., Ouadii, K., Bouchbika, Z., Benchakroun, N., Jouhadi, H., Tawfiq, N., Benider, A., Marnissi, F., Madani, A., Karkouri, M. and Sahraoui, S. (2022) Primary Testicular Lymphoma: A Case Report and Review of the Literature. Journal of Cancer Therapy, 13, 145-154. https://doi.org/10.4236/jct.2022.133011 Received: February 10, 2022 Accepted: March 18, 2022 Published: March 21, 2022 Copyright © 2022 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70993603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effect of COVID-19 on the Cancer Patients Treated with Radiotherapy in Low Risk Area: A Single-Center Descriptive COVID-19对低风险地区肿瘤放疗患者的影响:单中心描述性研究
Pub Date : 2022-01-01 DOI: 10.4236/jct.2022.135023
P. Zheng, Junyi Cao, Ke Liu, Y. Pang, Dong Wang
{"title":"The Effect of COVID-19 on the Cancer Patients Treated with Radiotherapy in Low Risk Area: A Single-Center Descriptive","authors":"P. Zheng, Junyi Cao, Ke Liu, Y. Pang, Dong Wang","doi":"10.4236/jct.2022.135023","DOIUrl":"https://doi.org/10.4236/jct.2022.135023","url":null,"abstract":"","PeriodicalId":66197,"journal":{"name":"癌症治疗(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70993953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
癌症治疗(英文)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1